1Palmer RM, Ferrige AG, Moncada S. Nitric oxide rdease accounts for the biological activity of endothelium- derived relaxing factor. Nature, 1987, 327: 524.
2Culott E, Koshland D E. No news is good News. Science,1992, 258: 1862.
3Sarah Rose, Gillian M, Mackenzie, et al. Nitric Oxide and Basal Ganglia Degeneration. Parkinson's disease: Advances in Neurology, 1999, Vol (80)-- 247-254.
4Beal MF. Excitotoxicity and Nitric Oxide in Parkinson's disease pathogenesis. Ann Neuro, 1998, 44 (Suppll): 110--114.
5Youdim MBH, Lavie L, Riedever P. Oxygea free radicals and neurodegeneration in Parkinson's disease: a role for nitric oxide.Ann NY Acad Sci, 1994, 738: 64-68.
6Beal MF. Excitotoxicity and nitric oxide in Parkinson' s disease pathogenesis. Ann Neurol, 1998 sep. 44 (3 suppll): S110-114.
7Youdim MBH, Benshachar D, Eshel G, et al. The neurotoxicity of iron and nitric oxide. Adv Neurol, 1993, 60: 259--266.
8Faucheux BA, Nillesse N, Damier P, et al. Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson's disease. Proc Natl Acad Sci USA,1995, 92: 9603-9607.
9Dawson TM, Gonzalez- Zulueta M. Nitric oxide: diverse actions in the central and peripheral nervous systems [J]. Neuroscientist, 1998, 4: 96--142.
10Liu RH, Hotchkiss JH. Potential genotoxieity of chronically devated nitric oxide: a review. Mutat Res, 1995, 339:73--89.
